REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 78 filers reported holding REPROS THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $8,413,000 | 2.08% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,445,000 | 0.72% |
| RTW INVESTMENTS, LP | 232,830 | $1,730,000 | 0.54% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 185,500 | $1,378,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 509,060 | $3,782,000 | 0.34% |
| Opus Point Partners Management, LLC | 98,000 | $494,000 | 0.27% |
| J. Goldman & Co LP | 350,000 | $2,601,000 | 0.22% |
| CQS Cayman LP | 240,000 | $1,783,000 | 0.15% |
| Baker Brothers Advisors | 1,955,944 | $14,533,000 | 0.13% |
| Perceptive Advisors | 440,000 | $3,270,000 | 0.13% |